YOUNG KEVIN 4
4 · GILEAD SCIENCES INC · Filed Feb 13, 2018
Insider Transaction Report
Form 4
YOUNG KEVIN
EVP, Commercial Operations
Transactions
- Exercise/Conversion
Common Stock
2018-02-10+908→ 16,237 total - Tax Payment
Common Stock
2018-02-10$79.32/sh−425$33,711→ 15,812 total - Exercise/Conversion
Restricted Stock Unit
2018-02-10−908→ 3,184 total→ Common Stock (908 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.